Showing posts with label diabetes. Show all posts
Showing posts with label diabetes. Show all posts

Saturday, February 13, 2010

Time to wake up on obesity

There are a number of problems in this world but many of them pale in comparison with obesity.

Franklin's budget problem is minor. The trash fee is minuscule.

Jamie Oliver gave this talk at TED recently. It is a powerful and yet easy message to take a step on. Today.

Powerful? Wait until you see the wheelbarrow!



What are you going to do?
When are you going to start?


Monday, September 22, 2008

In the News - diabetes, Charter School

GHS
Posted Sep 22, 2008 @ 12:23 AM

FRANKLIN —

More than anything, Ivy Patten wants a cure for juvenile diabetes, so her 14-year-old son, Tyler, can live a normal life.

The possible complications he and others diabetics face are "not a pretty picture," she said: blindness, amputation, nerve damage, kidney problems and death.

"My fears are several. First, a cure will not come very soon. You're always afraid blood sugar is going to go too low and he'll go into a seizure, pass out and die, and it's a very real fear," Patten said.

Many things can trigger problems with a diabetic's blood-sugar level, she said, and often they are not under a person's control.

Technology can help people manage diabetes, she said, but that is not enough.

"We really need to get a cure ASAP," said Patten, especially because the longer a person has diabetes, the greater his or her chances of complications.

,,,,,

For more information about the walk at the Franklin Town Common on Saturday, Sept. 27, which takes place from 11 a.m. to 1 p.m., log on to www.hotshots4thecure.org.

Read the full article in the Milford Daily News here

-------------------------

Milford Daily News
Posted Sep 21, 2008 @ 11:43 PM

FRANKLIN —

Renting out the historic Red Brick School is a top priority for the Benjamin Franklin Classical Charter Public School, said Principal Kevin O'Malley.

"The topic is still under discussion here. I can assure you, it's a front-burner issue," O'Malley said.

Charter school officials have met with the Brick School Association and had several discussions with Town Administrator Jeffrey D. Nutting about leasing the nearby property.

O'Malley has introduced the topic to the charter school's board of trustees, who will discuss the prospect at their next meeting, on Oct. 2 at the school library, he said.

"The idea is to have position papers presented where we'll talk about whether it's a good idea or not a good idea for the school," O'Malley said, noting that he is unsure whether the board will vote on Oct. 2.

"We're at a point where it's in everyone's best interest to discuss this thing and come to a conclusion. If we don't decide (on Oct. 2), then we will very soon," he said.

Town officials have been great and are making the process easy, O'Malley said. He said the charter school community wants to give back to Franklin, too.

Read the full article in the Milford Daily News here

Thursday, March 13, 2008

Franklin Industry - Echo Therapeutics Inc

Help for diabetics on the way from Franklin:

A small Franklin company says it is developing a novel device that could potentially let diabetics continuously monitor their blood-sugar levels - without having to draw blood.

Echo Therapeutics Inc. is expected to say today the device passed one of its first key tests, a pilot study with two dozen patients in the intensive-care unit at Tufts Medical Center in Boston. The Symphony system, a disc about the size of a half dollar, is designed to read glucose levels through the skin and transmit the information wirelessly to a nearby computer or hand-held meter. Currently, diabetes patients must normally prick their skin to draw a few drops of blood and place them on a measuring strip.

"I think it's extremely promising," said Dr. Stanley Nasraway, a Tufts University School of Medicine professor and director of surgical intensive-care units at the medical center. Nasraway said Echo's experimental device appeared to be reliable, relatively accurate, and easy to use, though he cautioned that it must first be tested in much larger clinical trials with a wider group of patients.

Read the full article in the Boston Globe